CHEBI:193597 - ARS-1620

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name ARS-1620
ChEBI ID CHEBI:193597
Definition A qinazoline derivative carrying chloro and fluoro substituents at positions 6 and 8 respectively, a 2-fluoro-6-hydroxyphenyl group at position 7, and a 4-(prop-2-enoyl)piperazin-1-yl group at position 4. A potent, selective, and orally bioavailable covalent KRAS-G12C inhibitor, it inhibits the protein coding gene KRAS (Kirsten rat sarcoma virus) with high potency in cells and animals.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C21H17ClF2N4O2
Net Charge 0
Average Mass 430.840
Monoisotopic Mass 430.10081
InChI InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2
InChIKey ZRPZPNYZFSJUPA-UHFFFAOYSA-N
SMILES OC1=CC=CC(F)=C1C1=C(F)C2=NC=NC(N3CCN(CC3)C(=O)C=C)=C2C=C1Cl
Roles Classification
Biological Role(s): inhibitor
A substance that diminishes the rate of a chemical reaction.
antiviral agent
A substance that destroys or inhibits replication of viruses.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing ARS-1620 (CHEBI:193597) has role antineoplastic agent (CHEBI:35610)
ARS-1620 (CHEBI:193597) has role antiviral agent (CHEBI:22587)
ARS-1620 (CHEBI:193597) has role inhibitor (CHEBI:35222)
ARS-1620 (CHEBI:193597) is a quinazolines (CHEBI:38530)
IUPAC Name
1-{4-[(7Sa)-6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl]piperazin-1-yl}prop-2-en-1-one
Synonyms Sources
(S)-1-{4-[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl] piperazin-1-yl}propan-1-one PDBeChem
1-[4-[(7S)-6-chloro-8-fluoro-7-[(1S)-2-fluoro-6-hydroxyphenyl]-4-quinazolinyl]-1-piperazinyl]-2-propen-1-one ChEBI
ARS 1620 ChEBI
Manual Xref Database
91S PDBeChem
View more database links
Citations Waiting for Citations Types Sources
35158284 PubMed citation Europe PMC
35281897 PubMed citation Europe PMC
36099883 PubMed citation Europe PMC
Last Modified
18 October 2022